Capricor Therapeutics (CAPR) shares were up 4.5% in Tuesday trading after Piper Sandler upgraded the company's stock to overweight from neutral and adjusted its price target to $25 from $2.
Trading volume stood at about 4.1 million shares, compared with a daily average of about 6 million.
Price: $10.36, Change: $+0.45, Percent Change: +4.54%